The Executive Director of the American Chamber of Commerce in Albania (AmCham Albania), Mr. Neritan Mullaj, visited the premises of Glosarij AL, an AmCham member, to learn more about the company’s operations, its investments in pharmaceutical infrastructure, and its collaboration with MSD (Merck Sharp & Dohme), one of the leading companies in the U.S. pharmaceutical industry.
During the visit, the Chamber’s representative was introduced to the company’s operational activities, modern warehousing and distribution facilities, as well as the monitoring and control systems in place to ensure that pharmaceutical products are stored in accordance with required quality and safety standards. Particular attention was given to Glosarij AL’s collaboration with MSD, a U.S.-based company with an established track record in scientific research, pharmaceutical development, and innovative therapies. This collaboration illustrates the role that cooperation between Albanian companies and international pharmaceutical leaders can play in developing the domestic pharmaceutical sector and supporting patients’ access to modern medicines and treatment options.
Specialising in the import and wholesale distribution of pharmaceutical products and medical devices, Glosarij AL has invested in infrastructure and operational processes designed to safeguard product integrity throughout the supply chain. Compliance with regulatory requirements, continuous monitoring of storage conditions, and the implementation of international quality standards are essential aspects of the company’s operations, particularly in a sector where product quality and safety are directly linked to patient health. The visit also provided an opportunity to exchange views on developments and prospects in Albania’s pharmaceutical sector, the importance of long-term business relationships, and the need to foster an environment that supports the introduction of innovative products and therapies to the Albanian market.
AmCham Albania considers the development of the healthcare and pharmaceutical sectors an important part of its ongoing dialogue with the business community. Through direct engagement with its member companies, the Chamber seeks to gain a better understanding of sector-specific investments, challenges, and opportunities, while encouraging the exchange of expertise and cooperation with international partners.
Glosarij AL’s experience and its collaboration with MSD highlight the importance of investment in quality, infrastructure, and innovation. They also demonstrate the potential of Albanian-American business cooperation to support the development of a more modern pharmaceutical market, increasingly focused on patients’ needs and access to advanced treatment options.








